Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor and/or Sarcoma”

836 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 836 results

Testing effectiveness (Phase 2)Study completedNCT00297258
What this trial is testing

Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
GlaxoSmithKline 148
Early research (Phase 1)Ended earlyNCT00311558
What this trial is testing

Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma

Who this might be right for
Cancer
The Cleveland Clinic 18
Early research (Phase 1)Study completedNCT00638898
What this trial is testing

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

Who this might be right for
Solid TumorAdult Central Nervous System Germ Cell TumorAdult Rhabdomyosarcoma+27 more
City of Hope Medical Center 25
Not applicableStudy completedNCT02415816
What this trial is testing

Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas

Who this might be right for
Sarcoma, BoneSarcoma, Soft TissueOsteosarcoma+3 more
St. Jude Children's Research Hospital 98
Early research (Phase 1)Looking for participantsNCT06441331
What this trial is testing

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Who this might be right for
Somatostatin Receptor PositiveNETsLymphoma+5 more
ITM Solucin GmbH 20
Testing effectiveness (Phase 2)Ended earlyNCT01621477
What this trial is testing

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+4 more
St. Jude Children's Research Hospital 34
Testing effectiveness (Phase 2)Study completedNCT05093322
What this trial is testing

Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Solid TumorLymphomaOsteosarcoma+3 more
Hutchmed 13
Testing effectiveness (Phase 2)Study completedNCT02496741
What this trial is testing

Metformin And Chloroquine in IDH1/2-mutated Solid Tumors

Who this might be right for
GliomaCholangiocarcinomaChondrosarcoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 15
Early research (Phase 1)Study completedNCT00722293
What this trial is testing

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 111
Not applicableWithdrawnNCT04098887
What this trial is testing

Lattice Stereotactic Body Radiation Therapy (Lattice SBRT) for Localized Unresectable or Metastatic Conventional Type Chondrosarcoma

Who this might be right for
Metastatic Chondrosarcoma
Washington University School of Medicine
Very early researchStudy completedNCT06413095
What this trial is testing

PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS

Who this might be right for
Head and Neck Squamous Cell CarcinomaSoft Tissue Sarcoma
Presage Biosciences 13
Testing effectiveness (Phase 2)Study completedNCT02448537
What this trial is testing

A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas

Who this might be right for
Metastatic Sarcoma
Massachusetts General Hospital 42
Not applicableEnded earlyNCT03630601
What this trial is testing

Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers

Who this might be right for
Breast CarcinomaHealthy SubjectMalignant Soft Tissue Neoplasm+2 more
Roswell Park Cancer Institute 7
Testing effectiveness (Phase 2)UnknownNCT05952128
What this trial is testing

Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma

Who this might be right for
Sarcoma
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Looking for participantsNCT07602777
What this trial is testing

A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)

Who this might be right for
Sarcoma
GlaxoSmithKline 113
Large-scale testing (Phase 3)Active Not RecruitingNCT03914612
What this trial is testing

Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated CarcinomaEndometrial Endometrioid Adenocarcinoma+13 more
National Cancer Institute (NCI) 813
Testing effectiveness (Phase 2)Study completedNCT01653028
What this trial is testing

Alisertib in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
MyxofibrosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Leiomyosarcoma+5 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)UnknownNCT02732678
What this trial is testing

Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO)

Who this might be right for
Angiosarcoma
Assistance Publique Hopitaux De Marseille 24
Testing effectiveness (Phase 2)Study completedNCT01222715
What this trial is testing

Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

Who this might be right for
Adult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Pleomorphic Rhabdomyosarcoma+4 more
National Cancer Institute (NCI) 87
Early research (Phase 1)WithdrawnNCT01697514
What this trial is testing

LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma

Who this might be right for
Medulloblastoma, ChildhoodRhabdomyosarcoma
Eli Lilly and Company
Next Page